InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding InMed Pharmaceuticals Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 560.2K | 409.8K | −150.4K (−26.9%) |
| Value | $979.9K | $536.4K | −$443.5K (−45.3%) |
New holders (7)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 205,800 | $270.0K | 0.00% |
| Two Sigma Investments, LP | 131,673 | $172.0K | 0.00% |
| Renaissance Technologies LLC | 44,200 | $58.0K | 0.00% |
| TD Waterhouse Canada Inc. | 2,130 | $3.68K | 0.00% |
| Reilly Financial Advisors, LLC | 700 | $1.00K | 0.00% |
| National Bank of Canada | 347 | $0 | 0.00% |
| Carroll Financial Associates, Inc. | 136 | $0 | 0.00% |
Sold out (8)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Armistice Capital, LLC | 510,000 | $893.0K |
| Virtu Financial LLC | 11,344 | $20.0K |
| UBS Group AG | 4,861 | $9.00K |
| The PNC Financial Services Group, Inc. | 1,820 | $3.00K |
| FourThought Financial, LLC | 424 | $1.00K |
| Morgan Stanley | 42 | $0 |
| Better Money Decisions, LLC | 100 | $0 |
| Navigation Wealth Management, Inc. | 65 | – |